tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
Australian Market

Paradigm Biopharmaceuticals (PAR) Financial Statements

Compare
39 Followers

Paradigm Biopharmaceuticals Financial Overview

Paradigm Biopharmaceuticals's market cap is currently AU$145.21M. The company's EPS TTM is AU$-0.033; its P/E ratio is -6.54; Paradigm Biopharmaceuticals is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 52.12KAU$ 65.80KAU$ 46.76KAU$ 79.22KAU$ 20.55K
Gross ProfitAU$ -19.89KAU$ 56.81KAU$ -18.83KAU$ -64.53KAU$ -78.59K
Operating IncomeAU$ -22.89MAU$ -65.19MAU$ -59.22MAU$ -47.01MAU$ -42.34M
EBITDAAU$ -25.25MAU$ -64.54MAU$ -59.06MAU$ -46.82MAU$ -42.40M
Net IncomeAU$ -18.77MAU$ -58.65MAU$ -51.91MAU$ -39.25MAU$ -34.30M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 16.82MAU$ 17.87MAU$ 56.38MAU$ 39.72MAU$ 71.08M
Total AssetsAU$ 24.57MAU$ 27.39MAU$ 67.07MAU$ 50.69MAU$ 84.79M
Total DebtAU$ 5.48KAU$ 239.33KAU$ 341.67KAU$ 616.67KAU$ 751.84K
Net DebtAU$ -16.81MAU$ -17.58MAU$ -55.99MAU$ -39.06MAU$ -70.28M
Total LiabilitiesAU$ 3.39MAU$ 3.58MAU$ 13.39MAU$ 8.38MAU$ 6.52M
Stockholders' EquityAU$ 21.18MAU$ 23.81MAU$ 53.68MAU$ 42.31MAU$ 78.27M
Cash Flow
Free Cash FlowAU$ -15.99MAU$ -65.94MAU$ -45.19MAU$ -32.21MAU$ -34.96M
Operating Cash FlowAU$ -15.99MAU$ -65.94MAU$ -45.19MAU$ -32.21MAU$ -34.93M
Investing Cash FlowAU$ 46.20KAU$ 0.00AU$ 0.00AU$ 0.00AU$ 668.37K
Financing Cash FlowAU$ 14.99MAU$ 28.18MAU$ 62.53MAU$ 70.12KAU$ 1.00M
Currency in AUD

Paradigm Biopharmaceuticals Earnings and Revenue History

Paradigm Biopharmaceuticals Debt to Assets

Paradigm Biopharmaceuticals Cash Flow

Paradigm Biopharmaceuticals Forecast EPS vs Actual EPS